Loading clinical trials...
Loading clinical trials...
An Open-Label Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Conditions
Interventions
Adalimumab
Start Date
May 1, 2012
Primary Completion Date
April 1, 2015
Completion Date
April 1, 2015
Last Updated
July 2, 2018
NCT07550673
NCT06372613
NCT07374471
NCT05739864
NCT06071312
NCT04338204
Lead Sponsor
AbbVie (prior sponsor, Abbott)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions